Academic Journal
Q2Pituitary
About Pituitary
Pituitary is a scholarly journal published by Springer. SCImago 2025 lists it in Q2, with an SJR of 1.16 and H-index of 88.
Coverage: 1998-2026. Research categories: Endocrinology (Q2); Endocrinology, Diabetes and Metabolism (Q2).
Verified field sources
- Journal Impact Factor: 3.4 — Official source; checked 2026-10-03. Journal metric year and editorial leadership as listed on the Springer Nature journal homepage.
- Impact Factor year: 2024 — Official source; checked 2026-10-03. Journal metric year and editorial leadership as listed on the Springer Nature journal homepage.
- Editor(s): Andrea Giustina MD (Editor-in-Chief) — Official source; checked 2026-10-03. Journal metric year and editorial leadership as listed on the Springer Nature journal homepage.
Source-backed journal facts
Topics in published research
Pituitary Gland Disorders and Treatments; Growth Hormone and Insulin-like Growth Factors; Adrenal and Paraganglionic Tumors; Adrenal Hormones and Disorders; Glioma Diagnosis and Treatment; Meningioma and schwannoma management.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Reported open-access list prices
4,490.00 USD; 3,790.00 EUR; 2,990.00 GBP
APC list prices reported by OpenAlex, which obtains this information from DOAJ. Confirm current charges, taxes, waivers and eligibility with the publisher; this is not a fee quotation.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Hypothalamic obesity in pediatric vs. adult craniopharyngioma: mechanisms, management, and cardiometabolic outcomes
Khushal Gupta, Maryam Zeinali, David Altschul, Vijay Agarwal et al.
2026-10 · DOI: 10.1007/s11102-026-01760-zStaining collagen fibers in pituitary lesions substantially improves the certainty of intraoperative frozen section diagnosis
Ursula Keber, Rima Yeghiazaryan, Axel Pagenstecher
2026-10 · DOI: 10.1007/s11102-026-01763-wPituitary Society Delphi consensus on the role of radiotherapy for pituitary adenomas
Frederic Castinetti, Cecilia Piazzola, John Ayuk, Michael Kosmin et al.
2026-10 · DOI: 10.1007/s11102-026-01759-6Pasireotide-LAR and pegvisomant combination in resistant acromegaly: a case series of predominantly mammosomatotroph adenomas
Edward Mignone, Elena V. Varlamov, Rinki Pandya, Melanie Hakar et al.
2026-10 · DOI: 10.1007/s11102-026-01750-1Prolactinoma assessment and management: an international multidisciplinary cross-sectional survey of current practice
Sunita M. C. De Sousa, Hani J. Marcus, Christopher D. Ovenden, Daniel Prevedello et al.
2026-10 · DOI: 10.1007/s11102-026-01757-8Infiltrative and inflammatory systemic disorders involving the pituitary gland
Betina Biagetti, Pedro Marques, Silvana Sarria-Estrada, Manel Puig-Domingo et al.
2026-10 · DOI: 10.1007/s11102-026-01758-7Long term neuropsychological evaluation of adult patients with craniopharyngiomas
Julie Guillotin, Charlotte Planchon, Julien Engelhardt, Edouard Gimbert et al.
2026-10 · DOI: 10.1007/s11102-026-01742-1Importance of clinical profiling to determine excess mortality in prolactinomas: insights from a large, registry-based cohort
Tarik Ziyad Tarik Shwaish, Davide Gori, Claudio Sartori, Federica Guaraldi et al.
2026-10 · DOI: 10.1007/s11102-026-01739-wInternal validation of THINKERS-PA for outcome prediction after pituitary adenoma radiosurgery
Jheremy S. Reyes, Constantinos G. Hadjipanayis, Georgios Zenonos, L Dade Lunsford et al.
2026-10 · DOI: 10.1007/s11102-026-01756-9Association between preoperative MRI radiomic features and methylation-defined phenotypes in non-functioning pituitary adenomas
Ilies Djebbara, Morten Winkler Møller, Ivar Yannick Christensen, Bo Halle et al.
2026-10 · DOI: 10.1007/s11102-026-01755-wCorrection: Long-term cabergoline use does not predict degree of prolactinoma fibrosis nor significantly impact surgical outcomes
Adam N. Mamelak, Rachel Fox, Yaakov Rosenberg, Daniel Gomez et al.
2026-10 · DOI: 10.1007/s11102-026-01734-1Correction to: The effect of centralized care on the management of postoperative fluctuations in plasma sodium concentration after pediatric suprasellar brain tumor surgery
S. C. Hulsmann, D. C. Zaal, J. P. J. van Gestel, M. Sie et al.
2026-10 · DOI: 10.1007/s11102-026-01723-4Evaluation of endothelial dysfunction in women with prolactinoma
Mehmet Cagri Unal, Osman Onur Daloglu, Ugur Karabiyik, Nihat Kalay et al.
2026-10 · DOI: 10.1007/s11102-026-01754-xDiagnostic value of the TRH test for central hypothyroidism in patients with pituitary and parasellar tumors: a single-center retrospective cross-sectional study
Battsetseg Buyandalai, Tetsuya Takamizawa, Kazuhiko Horiguchi, Sho Sekiguchi et al.
2026-10 · DOI: 10.1007/s11102-026-01751-0Beyond biochemical control: factors associated with quality of life in patients with acromegaly
Ayşe Merve Ok Kurt, Özge Telci Çaklılı, Fatih Bektaş, Gamze Bilik Oyman et al.
2026-10 · DOI: 10.1007/s11102-026-01746-xClinical presentation, investigation findings, and outcomes of hypophysitis in sarcoidosis: a systematic review
Julia F B Cavalcanti, Sara Caixeta de Souza, Leandro Tavares Lucato, Andrea Glezer et al.
2026-10 · DOI: 10.1007/s11102-026-01753-yArtificial intelligence in pituitary medicine: what should an endocrinologist know?
Damla N. Costa, Rozalina G. McCoy, Debraj Mukherjee, Roberto Salvatori et al.
2026-10 · DOI: 10.1007/s11102-026-01747-wRevival of neurophysin-I as a complementary biomarker for circulating oxytocin
Elizabeth A. Lawson
2026-10 · DOI: 10.1007/s11102-026-01745-yLong-term endocrine outcomes of transsphenoidal surgery for prolactinomas: a 20-year single-center cohort study
Roméo Bujiriri Murhega, Stefan Matei Constantinescu, Christian Raftopoulos, Dominique Maiter et al.
2026-10 · DOI: 10.1007/s11102-026-01749-8Soluble alpha-klotho as an adjunct biomarker of disease activity in acromegaly: Added value beyond GH and IGF-1
Vivek Jha, Sanja Medenica, Naresh Sachdeva, Vaishali Kaur et al.
2026-10 · DOI: 10.1007/s11102-026-01748-9Reviews
Community Reviews
Version History
September 25, 2026 at 7:46 am
September 25, 2026